Exponent, Inc. (NASDAQ:EXPO) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders
On June 1, 2017, we held our annual meeting of stockholders. A
total of 25,871,157 shares of our common stock were outstanding
as of April 4, 2017, the record date for the annual meeting. Set
forth below are the matters acted upon at the annual meeting and
the final voting results on each matter as reported by our
inspector of elections.
Proposal One: Election of Directors
Our stockholders elected Michael Gaulke, Paul Johnson, Ph.D.,
Carol Lindstrom, Karen Richardson, John Shoven, Ph.D., and Debra
Zumwalt. The results of the vote were as follows:
Votes For | Votes Against | Abstentions | Broker non-votes | |||||
Michael Gaulke | 22,678,751 | 99,995 | 22,788 | 2,381,362 | ||||
Paul Johnston, Ph.D. | 22,752,246 | 39,604 | 9,684 | 2,381,362 | ||||
Carol Lindstrom | 22,745,869 | 46,181 | 9,484 | 2,381,362 | ||||
Karen Richardson | 22,741,558 | 49,721 | 10,255 | 2,381,362 | ||||
John Shoven, Ph.D. | 22,632,499 | 157,235 | 11,800 | 2,381,362 | ||||
Debra Zumwalt | 22,737,198 | 54,817 | 9,519 | 2,381,362 |
Proposal Two: Ratification of KPMG as our Independent
Registered Public Accountants for Fiscal 2017
Our stockholders ratified our selection of KPMG LLP as our
independent registered public accounting firm to audit our
financial statements for the year ending December 29, 2017. The
results of the vote were as follows:
For | 25,068,549 |
Against | 111,878 |
Abstentions | 2,469 |
Proposal Three: Advisory Vote on Executive Compensation for
Fiscal 2016
Our stockholders approved, on an advisory basis, the fiscal 2016
compensation of our named executive officers in accordance with
SEC rules. The results of the vote were as follows:
For | 22,204,330 |
Against | 563,073 |
Abstentions | 34,131 |
Broker non-votes | 2,381,362 |
Proposal Four: Advisory Vote on Frequency of Stockholder
Advisory Votes on Executive Compensation
Our stockholders selected a frequency of one year, on an advisory
basis, to conduct an advisory vote on our named executive officer
compensation. The results of the vote were as follows:
One year | 19,032,297 |
Two years | 52,257 |
Three years | 3,702,866 |
Abstain | 14,114 |
Proposal Five: Approval of Amendment of the Amended and
Restated 2008 Equity Incentive Plan
Our stockholders voted to amend our Amended and Restated 2008
Equity Incentive Plan to increase the maximum number of shares of
our common stock issuable under the plan to 5,928,150 shares. The
results of the vote were as follows:
For | 22,517,639 |
Against | 267,172 |
Abstentions | 16,723 |
Broker non-votes | 2,381,362 |
Proposal Six: Approval of Amendment of the 2008 Employee
Stock Purchase Plan
Our stockholders voted to amend our 2008 Employee Stock Purchase
Plan to increase the maximum number of shares of our common stock
issuable under the plan to 600,000 shares. The results of the
vote were as follows:
For | 22,749,047 |
Against | 37,577 |
Abstentions | 14,910 |
Broker non-votes | 2,381,362 |
Item 8.01. Other Events
On June 1, 2017, our Board of Directors appointed Karen
Richardson as Audit Committee Chairperson. The Board of Directors
also determined that Karen Richardson and John Shoven are audit
committee financial experts as such term is defined by applicable
SEC regulations and the NASDAQ Global Select Market rules.
About Exponent, Inc. (NASDAQ:EXPO)
Exponent, Inc., along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services. Its Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences; epidemiology, biostatistics and computational biology; occupational and environmental health risk assessment, and toxicology and mechanistic biology.
Exponent, Inc. (NASDAQ:EXPO) Recent Trading Information
Exponent, Inc. (NASDAQ:EXPO) closed its last trading session up +1.00 at 60.40 with 153,692 shares trading hands.